Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Actinogen Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
Dr Boreham’s Crucible: Actinogen on the mend after a near-death experience
News
Weekly ASX small cap wrap: Who’ll forget to turn their clocks forward?
Health & Biotech
Check-up: Remarkable recovery has two big biotech losers talk of the town
News
Rise & Shine: What you need to know before the ASX opens
News
Lunchtime ASX small cap wrap: Who’s surfing into camp?
Health & Biotech
Health: Actinogen recovers some hope from Xanamem wreckage
News
10 at 10: These ASX stocks are on the dancefloor this morning
News
Rise & Shine: What you need to know before the ASX opens
News
Rise & Shine: What you need to know before the ASX opens
News
Hot Money Monday: These are the most in-demand stocks on the ASX right now
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: Actinogen’s Alzheimer’s treatment comes up short, stock crashes 70pc
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
There’s a bit of promise for health small caps in the federal Budget – but there’s also a big ‘if’
Health & Biotech
This health small cap has grown by more than 8000pc in the last decade
Health & Biotech
Why Actinogen’s progress is good news for Alzheimer’s patients and investors
Health & Biotech